Dr. Ikechukwu B. Moses, winner of the ESCMID Global 2025 Emerging Young Investigator Award, explores antimicrobial resistance through a One Health lens. His work spans zoonotic pathogen transmission, bacteriophage therapy, and AI-driven genomic research, aiming to reduce antibiotic reliance and translate lab-based innovations into scalable, real-world clinical and veterinary solutions.
For more than 40 years, Rebecca Denison has lived with HIV and advocated for women affected by the virus. A longtime activist and founder of WORLD, she has witnessed the epidemic’s evolution. In this interview, she reflects on scientific progress, ongoing challenges, and why the fight against HIV is far from over.
Dr Simon Feys discusses his award-winning research on viral-associated pulmonary aspergillosis (VAPA) in critically ill patients, highlighting key insights into its pathophysiology, diagnostic challenges, and treatment gaps. His work combines clinical expertise with multi-omics analysis to improve understanding, detection, and management of this often-overlooked but potentially deadly fungal superinfection.
The US Food and Drug Administration (FDA) has approved the first virus-like particle (VLP) chikungunya vaccine PXVX0317 (VIMKUNYAâ„¢), for individuals aged 12 years and older, with Bavarian Nordic recently announcing its commercial launch.1,2 This approval addresses a critical unmet need for effective prevention of chikungunya virus infections in endemic regions. Prior to this, the only […]
A double-stranded DNA virus of the Orthopoxvirus family, mpox (formerly monkeypox), continues to infect people daily, following the 2022 global outbreak.1 Two clades (clade 1 and clade 2) have been identified, with the 2022 outbreak caused by a subclade of clade 2, referred to as ...
Welcome to the latest edition of touchREVIEWS in Infectious Diseases, where we continue our mission to deliver insightful, cutting-edge perspectives in infectious disease diagnosis and management. This issue offers an array of topics spanning diagnostics, service delivery innovations and preventive ...
In this episode, we explore how point-of-care testing is transforming the management of sexually transmitted infections (STIs). Joined by Dr Libby van Gerwen, we discuss the rising global STI rates and the role these innovative tests play in addressing the issue. We also explore the challenges current point-of-care tests face and how next-generation advancements could further transform the future of STI diagnosis and treatment.
Highlights Determining infection and multidrug resistance (MDR) rates continuously helps to detect the problem to be solved, including outbreaks. Cleaning and disinfection play an important role in preventing MDR and evaluating and correcting the process for better results. MDR control ...
Sponsored content from GSK. Watch leading experts Jeremy Szeto and Kristen Robillard discuss their personal experience with adult immunization programs and the approaches they use in their practices to help optimize adult immunization rates.
Share your knowledge, influence clinical practices and enhance patient care in Infectious Diseases today!
Two experts discuss best practices for antiretroviral therapy (ART) selection for people living with HIV.
Watch three experts describe the HIV life cycle, the rationale for ART and how to manage ART resistance.
The expansion of HIV treatment access during the past two decades, particularly in low- and middle-income countries, stands as a significant accomplishment in the field of public health.1Â Currently, there are an estimated 30 million people on antiretroviral treatment for HIV ...
Respiratory syncytial virus (RSV) is often of increased concern in the autumn and winter months, especially for women who are pregnant, or those with newborns.1Â Worldwide, RSV is the second leading cause of death (second to malaria) in children during ...
Vaginal symptoms are one of the most common reasons for women accessing acute healthcare in the USA.1Â Vaginitis is most commonly evaluated based on clinical observations, including assessment of discharge characteristics, vaginal pH and, in some settings, microscopic examination of ...
We are excited to introduce the latest edition of touchREVIEWS in Infectious Diseases. Our mission is to bring you thought-provoking interviews, reviews, editorials, case studies and original research within the realm of infectious diseases. We aspire to engage infectious disease ...
The treatment of people with HIV (PWH)/hepatitis B virus (HBV) co-infection, especially those who have additional comorbidities requiring multiple drug therapies can be problematic. Bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) is a co-formulated medication consisting of two components ...
By sharing, listening and gaining an understanding of the real-life experiences of individuals living with a condition, clinicians and patients can better work together to improve care and outcomes and shape the healthcare system and policy of the future. Patient ...
Despite being the most severe form of viral hepatitis, there is no FDA-approved therapy for chronic hepatitis delta (CHD).1 Patients with CHD can progress to cirrhosis, as early as 5–10 years after infection. Further complications can also develop, such as esophageal ...
Article highlights Erythrasma is a common chronic superficial cutaneous bacterial infection caused by Corynebacterium minutissimum when conditions are conducive. Corynebacterium minutissimum produces coproporphyrin III (a phosphor) that emits a coral pink fluorescence under Wood’s lamp and helps confirm the ...
HIV is a significant global health issue for which there is no cure. However, the availability of antiretroviral therapy (ART) has made it possible to effectively treat and prevent HIV infection, leading to a considerable decrease in associated deaths and ...
Heavily treatment-experienced people living with HIV (HTE-PLWH) represent a minority of those living with HIV.1Â While there is variability in the definitions of HTE-PLWH, its prevalence is estimated to be between 1 and 10% of the total number of people living with ...
Introducing the Editorial Board of touchREVIEWS in Infectious Diseases, who support our mission to advance medical knowledge and practice by ensuring the integrity, relevance, and impact of the content we publish. Together, we strive to foster a vibrant academic community and contribute to the continuous improvement of healthcare worldwide.
HIV
Assistant Professor, Division of Infectious Diseases, Rutgers New Jersey Medical School, Newark, NJ, USA
Amesika Nyaku, MD MS is an Assistant Professor in the Division of Infectious Diseases at Rutgers New Jersey Medical School and a physician-scientist. She provides clinical care for people living with HIV or other infectious diseases and substance use disorders. Her research interests lie at the intersection of HIV and substance use disorders. She focuses on 1) evaluating long-acting therapeutics for HIV and opioid use disorder, 2) the implementation of integrated care models for HIV and substance use disorders to improve health outcomes, and 3) increasing the inclusion and participation of racial/ethnic minorities in clinical trials research. She is also co-director of the Northern New Jersey Medication-Assisted Treatment Center of Excellence that is tasked with assisting the state in expanding access to medication-assisted treatment for opioid use disorder through education, novel service delivery and community collaboration.
Fungal & Respiratory Infections
Dr. Jon Salmanton-GarcÃa is a researcher specializing in infectious diseases in immunocompromised patients, with a particular focus on respiratory viral infections in hematology and fungal diseases. He holds a PhD in Health Sciences from the University of Cologne and has published numerous scientific articles while presenting his work at national and international congresses. He serves as the scientific coordinator of the EPICOVIDEHA registry, which investigates respiratory viral infections in hematological patients, and leads the Diagnostic and Treatment Capacity of Invasive Fungal Infections initiative. Additionally, he has held leadership roles in European medical associations, contributing to advances in infection management for vulnerable populations.
Dr. Jon Salmanton-GarcÃa is a researcher specializing in infectious diseases in immunocompromised patients, with a particular focus on respiratory viral infections in hematology and fungal diseases. He holds a PhD in Health Sciences from the University of Cologne and has published numerous scientific articles while presenting his work at national and international congresses. He serves as the scientific coordinator of the EPICOVIDEHA registry, which investigates respiratory viral infections in hematological patients, and leads the Diagnostic and Treatment Capacity of Invasive Fungal Infections initiative. Additionally, he has held leadership roles in European medical associations, contributing to advances in infection management for vulnerable populations.
Antimicrobial Resistance
Ikechukwu B. Moses, Ph.D., is a FAPESP Postdoctoral Research Fellow at the Division of Infectious Diseases, Paulista School of Medicine (EPM), Federal University of Sao Paulo (UNIFESP), Brazil. He specializes in antimicrobial resistance and infectious diseases. Dr. Moses earned his Ph.D. in Pharmaceutical Microbiology & Biotechnology from Nnamdi Azikiwe University, Nigeria in November, 2019 and has a background in Microbiology from Obafemi Awolowo University, Nigeria. He has held positions as a Postdoctoral Research Fellow at Universitas Airlangga, Indonesia, and as a Lecturer at Ebonyi State University, Nigeria. His research focuses on antimicrobial resistance, microbial immune evasion, and alternative therapeutic approaches in veterinary, pharmaceutical, and medical microbiology.
Ikechukwu B. Moses, Ph.D., is a FAPESP Postdoctoral Research Fellow at the Division of Infectious Diseases, Paulista School of Medicine (EPM), Federal University of Sao Paulo (UNIFESP), Brazil. He specializes in antimicrobial resistance and infectious diseases. Dr. Moses earned his Ph.D. in Pharmaceutical Microbiology & Biotechnology from Nnamdi Azikiwe University, Nigeria in November, 2019 and has a background in Microbiology from Obafemi Awolowo University, Nigeria. He has held positions as a Postdoctoral Research Fellow at Universitas Airlangga, Indonesia, and as a Lecturer at Ebonyi State University, Nigeria. His research focuses on antimicrobial resistance, microbial immune evasion, and alternative therapeutic approaches in veterinary, pharmaceutical, and medical microbiology.
Sexually Transmitted Infections
Assistant Professor, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA
Dr Olivia Van Gerwen completed her internal medicine residency and chief residency at Tulane University in New Orleans, LA. She returned to her hometown of Birmingham, AL to pursue a fellowship in Infectious Diseases at UAB, which she completed in 2020 in addition to a post-doctoral fellowship in health services, outcomes, and effectiveness research. She is now an Assistant Professor in the University of Alabama at Birmingham (UAB) Division of Infectious Diseases. Olivia’s research focuses on HIV and STI prevention as well as comprehensive sexual health promotion among LGBTQ+ populations. Clinically, she enjoys providing sexual healthcare services to patients at the UAB Gender Health clinic, patients living with HIV at the UAB 1917 Clinic and is the Assistant Medical Director at the UAB Vaginitis Clinic.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.